Bromadol BDPC, the relatively created pain reliever, has unique chemical characteristics. It mainly functions as the limited μ-opioid binding site stimulant, also indicates significant influence with the κ-opioid binding site as well. This combined effect produces at the complex profile of consequences, such as analgesia, relaxation, plus mayb